Unicycive Therapeutics Stock Price on April 10, 2024
| UNCY Stock | USD 0.68 0.09 15.25% |
If you're considering investing in Unicycive Stock, it is important to understand the factors that can impact its price. As of today, the current price of Unicycive Therapeutics stands at 0.68, as last reported on the 29th of November, with the highest price reaching 0.74 and the lowest price hitting 0.61 during the day. Unicycive Therapeutics is dangerous given 3 months investment horizon. Unicycive Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.24, which indicates the firm had a 0.24% return per unit of risk over the last 3 months. We were able to break down thirty different technical indicators, which can help you to evaluate if expected returns of 1.35% are justified by taking the suggested risk. Use Unicycive Therapeutics Semi Deviation of 4.33, coefficient of variation of 504.41, and Risk Adjusted Performance of 0.1606 to evaluate company specific risk that cannot be diversified away.
At this time, Unicycive Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 31.7 M in 2024, whereas Common Stock is likely to drop slightly above 21.3 K in 2024. . Price To Sales Ratio is likely to drop to 16.04 in 2024. Price Earnings Ratio is likely to drop to -0.73 in 2024. Unicycive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Unicycive |
Sharpe Ratio = 0.2421
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | UNCY | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.59 actual daily | 49 51% of assets are more volatile |
Expected Return
| 1.35 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.24 actual daily | 19 81% of assets perform better |
Based on monthly moving average Unicycive Therapeutics is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Unicycive Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.5265 | Enterprise Value Ebitda (1.03) | Price Sales 62.819 | Shares Float 61.5 M | Wall Street Target Price 5.5 |
Related Headline
Enliven Therapeutics Headline on 10th of April 2024
Disposition of 13600 shares by Ballal Rahul D. of Enliven Th... by Ballal Rahul D.
Filed transaction by Enliven Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Unicycive Therapeutics Valuation on April 10, 2024
It is possible to determine the worth of Unicycive Therapeutics on a given historical date. On April 10, 2024 Unicycive was worth 1.32 at the beginning of the trading date compared to the closed value of 1.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Unicycive Therapeutics stock. Still, in general, we apply an absolute valuation method to find Unicycive Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Unicycive Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Unicycive Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.37 | 1.39 | 1.29 | 1.32 | 246,826 | |
04/10/2024 | 1.32 | 1.32 | 1.26 | 1.30 | 172,987 |
| 1.35 | 1.35 | 1.25 | 1.25 | 121,707 |
| Backtest Unicycive Therapeutics | | | Unicycive Therapeutics History | | | Unicycive Therapeutics Valuation | Previous | Next |
Unicycive Therapeutics Trading Date Momentum on April 10, 2024
| On April 11 2024 Unicycive Therapeutics was traded for 1.25 at the closing time. The top price for the day was 1.35 and the lowest listed price was 1.25 . The trading volume for the day was 121.7 K. The trading history from April 11, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.85% . The trading price change against the current closing price is 16.15% . |
Unicycive Therapeutics Fundamentals Correlations and Trends
By evaluating Unicycive Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Unicycive Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Unicycive financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Unicycive Therapeutics Stock history
Unicycive Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Unicycive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Unicycive Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Unicycive Therapeutics stock prices may prove useful in developing a viable investing in Unicycive Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.5 M | 18.7 M | |
| Net Loss | -9 M | -8.6 M |
Unicycive Therapeutics Stock Technical Analysis
Unicycive Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Unicycive Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Unicycive Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Unicycive Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Unicycive Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Unicycive Therapeutics shares will generate the highest return on investment. By undertsting and applying Unicycive Therapeutics stock market strength indicators, traders can identify Unicycive Therapeutics entry and exit signals to maximize returns
Unicycive Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Unicycive Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Unicycive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Unicycive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1606 | |||
| Jensen Alpha | 0.9253 | |||
| Total Risk Alpha | 0.2599 | |||
| Sortino Ratio | 0.1651 | |||
| Treynor Ratio | 0.6872 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Unicycive Stock Analysis
When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.